Legacy App users can now access the Health Portal – just reset your password using email as username.

Stenabolic SR-9009 – Metabolic Modulator

Stenabolic SR-9009 – Metabolic Modulator

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
Stenabolic SR-9009 is introduced as a metabolic modulator found on underground research sites. The speaker frames the goal as explaining history, mechanism, and real-world cautions.
01:31
The origin story points to a major research institute and rigorous early science. A key claim is that public human trials are missing, so certainty remains limited.
02:23
The mechanism centers on circadian nuclear receptor activity that influences metabolic gene expression. It ties circadian rhythm signaling to mitochondrial density and energy handling.
03:55
Performance benefits are discussed as better endurance and higher calorie burn at rest. Obesity and diabetes are named as potential targets for future metabolic therapies.
05:43
Attention shifts to dosing logistics, including short half-life and repeated daily administration. The transcript mentions oral drops, pills, and injections used in unregulated settings.
07:59
Anecdotal side effects are listed, including headaches and gastrointestinal upset in some users. Sleep changes, palpitations, and anxiety are mentioned while noting confounding drug stacks.
09:57
The speaker ends by urging caution with sourcing and with interpreting anecdotes as evidence. He encourages sharing experiences ethically while making careful, individualized decisions.

Video Summary

The transcript introduces Stenabolic SR-9009 as a powerful metabolic modulator sold underground. It is described as nonhormonal, and it is not treated like a typical anabolic steroid. The speaker says many sellers lump it with other research chemicals, which creates confusion. He traces its origins to high-level pharmaceutical research rather than bodybuilding folklore. A major point is that human trials are not found in the public record. Because of that gap, the talk leans on mechanism, animal outcomes, and user anecdotes. The tone is excited about the science while still emphasizing uncertainty for real people.

Mechanistically, SR-9009 is presented as a circadian nuclear receptor agonist affecting metabolism. The speaker links circadian rhythm signaling to energy production and mitochondrial density in muscle. In animal models, the compound is said to raise basal metabolic rate and improve endurance capacity. He repeatedly clarifies this is not intended for direct muscle building in the usual sense. Instead, the appeal is framed around fat burning, aerobic performance, and easier work output. Obesity and diabetes are cited as the big clinical targets where better metabolic tools are needed. The discussion asks where this compound might fit among modern weight loss drugs someday.

Practical questions focus on a very short half-life and the need for frequent daily dosing. Underground users are described as taking roughly twenty five to fifty milligrams per day. The transcript notes some people split doses four to six times daily, depending on the form. Routes discussed include oral liquids, pills, and even injections from research suppliers. Because sourcing is uncertain, the speaker warns that purity and labeling may be unreliable. Anecdotal side effects include headaches, nausea, vomiting, diarrhea, palpitations, and anxiety. The closing message urges caution, sharing experiences responsibly, and making personal decisions carefully.

Drug Callouts

Drug
Description
SR-9009 (Stenabolic)
SR-9009 is a synthetic research compound studied as a REV-ERB circadian receptor agonist. The transcript frames it as a metabolic modulator with only animal research and uncertain human safety.
Zolpidem (Ambien)
Zolpidem is a sedative hypnotic medication prescribed for short term treatment of insomnia. It is mentioned as an example of sleep medicine that can cause morning grogginess and tradeoffs.

Condition Callouts

Condition
Description
Obesity
Obesity is excess body fat that increases metabolic and cardiovascular disease risks over time. The transcript cites obesity as a key target for metabolic drugs like SR-9009 in theory.
Diabetes mellitus
Diabetes mellitus is chronic hyperglycemia caused by impaired insulin action, secretion, or both together. The speaker names diabetes as a major clinical area needing better metabolic treatments.
Anxiety
Anxiety is persistent excessive worry that can affect sleep, focus, and physical symptoms. It is listed among anecdotal side effects reported by some users taking SR-9009.

Key Takeaways

  • SR-9009 is presented as a nonhormonal metabolic modulator sold through underground sources.
  • The transcript states there are no public human trials, only animal research so far.
  • Animal data are described as higher mitochondrial density and better endurance performance.
  • Underground dosing is described as frequent administration because the half life seems short.
  • Anecdotal side effects include headaches, stomach upset, palpitations, and anxiety in some users.